Várvölgyi, T., Janka, E., Szász, I., Koroknai, V., Toka-Farkas, T., Szabó, I., Ványai, B., Szegedi, A., Emri, G., Balázs, M.: Combining Biomarkers for the Diagnosis of Metastatic Melanoma.
J Clin Med. 13 (1), 1-13, 2024.

Merzah, M., Póliska, S., Balogh, L., Sándor, J., Szász, I., Natae, S., Fiatal, S.: A Transcriptomic Analysis of Smoking-Induced Gene Expression Alterations in Coronary Artery Disease Patients.
Int. J. Mol. Sci. 24 (18), 1-14, 2023.

Koroknai, V., Szász, I., Jámbor, K., Balázs, M.: Expression pattern of osteopontin isoforms in malignant melanoma cell lines.
CTS-Clin. Transl. Sci. 17 (1), 1-10, 2023.

Koroknai, V., Szász, I., Balázs, M.: Gene Expression Changes in Cytokine and Chemokine Receptors in Association with Melanoma Liver Metastasis.
Int. J. Mol. Sci. 24 (10), 1-13, 2023.

Szász, I., Kiss, T., Mokánszki, A., Koroknai, V., Deák, J., Patel, V., Jámbor, K., Ádány, R., Balázs, M.: Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
Mol. Cell. Probes. 67 1-8, 2023.

Koroknai, V., Szász, I., Jámbor, K., Balázs, M.: Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines.
Int. J. Mol. Sci. 23 (5), 1-10, 2022.

Jámbor, K., Koroknai, V., Kiss, T., Szász, I., Pikó, P., Balázs, M.: Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma.
Pathol. Oncol. Res. 28 1-12, 2022.

Szász, I., Koroknai, V., Vízkeleti, L., Balázs, M.: BRAF-inhibitor-kezelést követően kialakult rezisztencia molekuláris háttere BRAFV600E mutáns melanóma-sejtvonalakban.
Magyar Onkol. 65 (2), 149-156, 2021.

Szász, I., Koroknai, V., Patel, V., Hajdú, T., Kiss, T., Ádány, R., Balázs, M.: Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines.
Biomedicines. 9 (2), 1-18, 2021.

Nagy, K., Tessema, R., Szász, I., Smeirat, T., Al Rajo, A., Ádám, B.: Micronucleus Formation Induced by Glyphosate and Glyphosate-Based Herbicides in Human Peripheral White Blood Cells.
Front. Public Health. 9 1-12, 2021.

Patel, V., Szász, I., Koroknai, V., Kiss, T., Balázs, M.: Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.
Cancers (Basel). 13 (23), 1-22, 2021.

Kiss, T., Jámbor, K., Koroknai, V., Szász, I., Bárdos, H., Mokánszki, A., Ádány, R., Balázs, M.: Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Pathol. Oncol. Res. 27 1-10, 2021.

Koroknai, V., Szász, I., Hernandez, -., Fernandez, -., Cuenin, C., Herceg, Z., Vízkeleti, L., Ádány, R., Ecsedi, S., Balázs, M.: DNA hypermethylation is associated with invasive phenotype of malignant melanoma.
Exp. Dermatol. 29 (1), 39-50, 2020.

Koroknai, V., Patel, V., Szász, I., Ádány, R., Balázs, M.: Gene Expression Signature of BRAF Inhibitor Resistant Melanoma Spheroids.
Pathol. Oncol. Res. 26 (4), 2557-2566, 2020.

Szász, I., Koroknai, V., Kiss, T., Vízkeleti, L., Ádány, R., Balázs, M.: Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells.
Melanoma Res. 29 (4), 390-400, 2019.

Balázs, M., Koroknai, V., Szász, I., Ecsedi, S.: Detection of CCND1 Locus Amplification by Fluorescence In Situ Hybridization.
In: The Retinoblastoma Protein. Ed.: Pedro G. Santiago-Cardona, Springer Science+Business Media, New York, NY, 85-100, 2018. ISBN: 9781493975648

Vízkeleti, L., Kiss, T., Koroknai, V., Ecsedi, S., Papp, O., Szász, I., Ádány, R., Balázs, M.: Altered integrin expression patterns revealed by microarray in human cutaneous melanoma.
Melanoma Res. 27 (3), 180-188, 2017.

Koroknai, V., Ecsedi, S., Vízkeleti, L., Kiss, T., Szász, I., Lukács, A., Papp, O., Ádány, R., Balázs, M.: Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.
Melanoma Res. 2 100-107, 2016.